Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Dec
7
2020
Prison for over 200 fraudulent Chinese patent applications yielding 900,000 RMB in government awards Schwegman, Lundberg & Woessner, P.A.
Feb
17
2021
Colgate-Palmolive Not Rebranding China’s Darlie/Black Person’s Toothpaste Based on Recent Trademark Filings? Schwegman, Lundberg & Woessner, P.A.
Mar
14
2021
China Releases Draft Measures for Administrative Adjudication of Major Patent Infringement Disputes for Comment Schwegman, Lundberg & Woessner, P.A.
Jul
5
2017
Cleveland Clinic v. True Health Diagnostics – Time to Redefine “Inventive Concept”? Schwegman, Lundberg & Woessner, P.A.
May
20
2021
China’s Center for Drug Evaluation Opens Patent Linkage Registration Platform for Public Testing Schwegman, Lundberg & Woessner, P.A.
Jul
20
2021
China’s General Administration of Customs Announces Typical Cases of Intellectual Property Infringement Schwegman, Lundberg & Woessner, P.A.
Feb
20
2015
Pacing Technologies v. Garmin – D&D Explained Schwegman, Lundberg & Woessner, P.A.
Jul
27
2021
Criminal Arrests for Intellectual Property Crimes in China Up 99% in H1 2021 Schwegman, Lundberg & Woessner, P.A.
Mar
9
2015
Novartis Wins Landmark Biosimilar Approval Schwegman, Lundberg & Woessner, P.A.
Mar
12
2015
Eidos Display, LLC v. AU Optronics Corp: Claim Definite Enough for those of Skill in the Art, even if Not the Eastern District of Texas Schwegman, Lundberg & Woessner, P.A.
Sep
17
2021
China’s National People’s Congress Releases Translation of the Amended Patent Law Schwegman, Lundberg & Woessner, P.A.
Sep
22
2021
The Central Committee of the Communist Party of China and the State Council issued the “Guidelines for Building a Powerful Country with Intellectual Property Rights (2021-2035)” Schwegman, Lundberg & Woessner, P.A.
Apr
5
2011
Factors in Deciding Motions to Stay Litigation Pending Reexamination Schwegman, Lundberg & Woessner, P.A.
Apr
25
2011
Petition Granted for Rehearing en banc of Akamai Technologies v. Limelight Networks Schwegman, Lundberg & Woessner, P.A.
May
8
2011
What Were They Thinking? A Second Look at Lilly v. Sun Schwegman, Lundberg & Woessner, P.A.
May
18
2011
Patent Office Broadens “First Action Interview” Pilot Program Schwegman, Lundberg & Woessner, P.A.
Feb
14
2022
China Cracks Down on Olympic Trademark Squatters Including Marks for Olympic Gold Medalist and Fashion Model Eileen Gu Schwegman, Lundberg & Woessner, P.A.
Feb
28
2022
China’s IP Tribunal of the Supreme People’s Court Releases Annual Report for 2021 Schwegman, Lundberg & Woessner, P.A.
Jan
10
2018
Aptalis Fails to “Surround’ Apotex’s Generic ER Tablet Schwegman, Lundberg & Woessner, P.A.
Aug
14
2015
Federal Circuit Rules Requirements for Direct Infringement by Multiple Parties Schwegman, Lundberg & Woessner, P.A.
Jul
23
2012
PTO Rules on Pre-issuance Submissions by Third Parties Schwegman, Lundberg & Woessner, P.A.
Sep
15
2022
Shanghai Intellectual Property Court: Continued Trademark Infringement After Notice Can Lead to Punitive Damages Schwegman, Lundberg & Woessner, P.A.
Oct
9
2022
China Plans to Extend Patent Agency Credit Rating System Nationwide in Administrative Measures for the Credit Evaluation of Patent Agency Draft for Public Comment Schwegman, Lundberg & Woessner, P.A.
Sep
4
2015
Sandoz Launches First Biosimilar Drug in U.S. Schwegman, Lundberg & Woessner, P.A.
Apr
20
2018
USPTO Memorandum Seeks to Clarify “Inventive Concept” Requirement Schwegman, Lundberg & Woessner, P.A.
Mar
8
2023
China To Upgrade Status of the China National Intellectual Property Administration Schwegman, Lundberg & Woessner, P.A.
Mar
9
2013
UK National Stem Cell Network Report – The Patent Watch Landscape Schwegman, Lundberg & Woessner, P.A.
Aug
15
2018
Ex Parte Nagy – The Reach of the Mayo/Alice Rule Exceeds Its Grasp? Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins